Hinge Health (HNGE) Stock Price, News & Analysis

Company Overview

Hinge Health, Inc. is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care designed to help members manage pain, improve mobility and avoid or delay more invasive treatments.

Its platform combines a mobile application, motion-sensing technology, personalized exercise therapy, education and support from a care team that may include clinical specialists. Hinge Health offers programs for conditions such as chronic back pain, knee pain and other common MSK issues, with services generally provided through employers, health plans and other healthcare organizations.

Hinge Health was founded in 2015 and is headquartered in San Francisco, California. The company primarily serves users in the United States and has expanded its digital MSK care services to additional markets, including the United Kingdom. Daniel Perez is a co-founder and serves as chief executive officer.

Key Stats

• Today's Range: $98.24 to $103.28
• 50-Day Range: $77.61 to $102.82
• 52-Week Range: $30.08 to $103.28
• Volume: 1.70 million shs
• Average Volume: 1.92 million shs
• Market Capitalization: $8.30 billion
• P/E Ratio: 80.33
• Dividend Yield: N/A
• Price Target: $105.33
• Consensus Rating: Moderate Buy

Hinge Health Stock Analysis - MarketRank™

Hinge Health scored higher than 50% of companies evaluated by MarketBeat, and ranked 529th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Hinge Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 1 strong buy rating, 15 buy ratings, 3 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Hinge Health is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Hinge Health has been the subject of 16 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 8.80%

Earnings Growth

Earnings for Hinge Health are expected to grow by 8.80% in the coming year, from $1.25 to $1.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Hinge Health is 80.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of Hinge Health is 80.33, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.02.

Price to Book Value per Share Ratio

Hinge Health has a P/B Ratio of 45.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.68% of the float of Hinge Health has been sold short.

Short Interest Ratio / Days to Cover

Hinge Health has a short interest ratio ("days to cover") of 3.33, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Hinge Health has recently increased by 31.09%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Hinge Health does not currently pay a dividend.

Dividend Growth

Hinge Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.44

News Sentiment

Hinge Health has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Hinge Health this week, compared to 4 articles on an average week.

Search Interest

Only 8 people have searched for HNGE on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.

MarketBeat Follows

8 people have added Hinge Health to their MarketBeat watchlist in the last 30 days. This is an increase of 14% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Hinge Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $70,085,397.00 in company stock.

Percentage Held by Insiders

18.92% of the stock of Hinge Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Hinge Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/10/2026
• Next Earnings (Confirmed): 11/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:HNGE
• Previous Symbol: NYSE:HNGE
• CIK: 1673743
• Web: www.hingehealth.com
• Phone: (415) 689-8429
• Fax: N/A
• Employees: 1,437
• Year Founded: 2014

Price Target and Rating

• Average Price Target for Hinge Health: $105.33
• High Price Target: $125.00
• Low Price Target: $80.00
• Potential Upside/Downside: +2.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.89
• Research Coverage: 19 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.28
• Trailing P/E Ratio: 80.33
• Forward P/E Ratio: 82.26
• P/E Growth: N/A
• Net Income: -$528.26 million
• Net Margins: 15.15%
• Pretax Margin: 15.41%
• Return on Equity: 51.60%
• Return on Assets: 14.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.34
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $587.86 million
• Price / Sales: 14.11
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.26 per share
• Price / Book: 45.50

Miscellaneous

• Outstanding Shares: 80,690,000
• Free Float: 65,427,000
• Market Cap: $8.30 billion
• Optionable: N/A
• Beta: 1.37